Ubiquitin-specific peptidase 22 (USP22) is identified as a key chromatin-based barrier to human iPSC derivation through a chromatin-focused CRISPR-Cas9 screen.
Advances in the gene-editing technology known as CRISPR-Cas9 over the past 15 years have yielded important new insights into ...